Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey

被引：0
|
作者：
Bianchi, Gerolamo [1 ]
Carletto, Antonio [2 ]
Epis, Oscar M. [3 ]
Scioscia, Crescenzio [4 ]
Semeraro, Angelo [5 ]
Donati, Chiara [6 ]
Bazzichi, Laura [7 ]
Lapadula, Giovanni [8 ]
Sinigaglia, Luigi [9 ]
Lo Monaco, Andrea [10 ]
机构：
[1] Osped La Colletta, Div Reumatol, Genoa, Italy
[2] Univ Verona, Rheumatol Unit, I-37100 Verona, Italy
[3] AO Osped Niguarda Ca Granda, Rheumatol Unit, Milan, Italy
[4] Univ Bari Aldo Moro, DIM Sez Reuamtol, Bari, Italy
[5] ASL Taranto, Unita Operat Reumatol, Taranto, Italy
[6] Roche SpA, Monza, Italy
[7] Univ Pisa, Div Reumatol, Pisa, Italy
[8] Univ Bari, DIMIMP Rheumatol Unit, Bari, Italy
[9] IOG Pini, Rheumatol Dept, Milan, Italy
[10] Osped S Anna Ferrara, Ferrara, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
498
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Disease-modifying anti-rheumatic drugs - Cyclosporin
    Chaudhuri, K
    Torley, H
    Madhok, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
  • [42] Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
    Choy, Ernest H.
    RHEUMATOLOGY, 2019, 58 : 51 - 55
  • [43] DISEASE MODIFYING ANTI-RHEUMATIC DRUG ADHERENCE IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS
    Ayano, Nakayama
    Bruce, Shadbolt
    Allison, Tong
    Kathleen, Tymms
    Chandima, Perera
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 17 - 17
  • [44] TIMING OF PNEUMOCOCCAL VACCINATIONS IN RELATION TO STARTING DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Costello, R. E.
    Humphreys, J.
    Winthrop, K.
    Dixon, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 961 - 962
  • [45] Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
    Hanaoka, Hironari
    Kikuchi, Jun
    Hiramoto, Kazuoto
    Saito, Shuntaro
    Kondo, Yasushi
    Kaneko, Yuko
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1373 - 1378
  • [46] ANA DEVELOPMENT IS ASSOCIATED WITH POOR RESPONSE TO BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ishikawa, Y.
    Hashimoto, M.
    Ito, H.
    Tanaka, M.
    Yukawa, N.
    Fujii, T.
    Mimori, T.
    Terao, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 107 - 108
  • [47] Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
    Tawaratsumida H.
    Setoguchi T.
    Arishima Y.
    Ohtsubo H.
    Akimoto M.
    Ishidou Y.
    Nagano S.
    Taketomi E.
    Sunahara N.
    Komiya S.
    BMC Research Notes, 10 (1)
  • [48] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
    Shimada, Hiromi
    Kameda, Tomohiro
    Kanenishi, Kenji
    Miyatake, Nobuyuki
    Nakashima, Shusaku
    Wakiya, Risa
    Kato, Mikiya
    Miyagi, Taichi
    Mansour, Mai Mahmoud Fahmy
    Hata, Toshiyuki
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1453 - 1458
  • [49] Combined treatment with leflunomide and methotrexate for patients with disease-modifying anti-rheumatic drugs naive active rheumatoid arthritis
    Lee, S.
    Park, Y.
    Kang, Y.
    Nam, E.
    Kim, S.
    Lee, J.
    Yoo, W.
    Lee, S.
    Park, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 342 - 342
  • [50] The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs
    Radner, Helga
    Yoshida, Kazuki
    Frits, Michelle
    Iannaccone, Christine
    Shadick, Nancy A.
    Weinblatt, Michael
    Smolen, Josef S.
    Solomon, Daniel H.
    RHEUMATOLOGY, 2015, 54 (11) : 2076 - 2084
12345